Oncology Institute, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

STLN

organization

SIC: 8011

SEC Insider

$218.9M

414 transactions

Summary

Oncology Institute, Inc. (STLN) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $104.5MSales: $56.8M38 insiders

Date	Insider	Type	Value
2026-03-27	Virnich Daniel(Chief Executive Officer)	J	$302K
2026-04-14	Kaushal Mohit	Sell	$201K
2026-05-20	Chernett Jorey	Buy	$136K
2026-04-16	Kaushal Mohit	Sell	$135K
2026-06-08	Podnos Yale(Chief Medical Officer)	Sell	$126K
2026-05-19	Chernett Jorey	Buy	$123K
2026-05-21	Virnich Daniel(Chief Executive Officer)	J	$103K
2026-06-23	Chernett Jorey	Buy	$90K
2026-03-27	Chernett Jorey	Buy	$81K
2026-03-27	Carter Robert Ross(Chief Financial Officer)	J	$62K
2026-04-09	Chernett Jorey	Buy	$62K
2026-06-04	Chernett Jorey	Buy	$57K
2026-03-27	Podnos Yale(Chief Medical Officer)	J	$50K
2026-05-19	Chernett Jorey	Buy	$20K
2026-05-21	Podnos Yale(Chief Medical Officer)	J	$8K
2026-05-21	Carter Robert Ross(Chief Financial Officer)	J	$7K
2026-03-27	Virnich Daniel(Chief Executive Officer)	A	$0
2026-03-27	Carter Robert Ross(Chief Financial Officer)	A	$0
2026-03-27	Podnos Yale(Chief Medical Officer)	A	$0
2026-03-27	England Kristin(Chief Administrative Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Oncology Institute, Inc. — Contributions, Lobbying & Contracts | Poliscope